Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys
about
Novel GPCR paradigms at the μ-opioid receptorAn intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-AmericansPutative kappa opioid heteromers as targets for developing analgesics free of adverse effects.Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.Heteroatom analogues of hydrocodone: synthesis and biological activityMolecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional ReceptorsG-protein-coupled receptor type A heteromers as an emerging therapeutic target.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.In vitro and in vivo characterisation of the bifunctional MOP/DOP ligand UFP-505.Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease.Analgesia linked to Nav1.7 loss of function requires µ- and δ-opioid receptors
P2860
Q26864286-9EFF3A23-DBDB-4A1A-9A4C-649E84853D7DQ30543145-E1D9947B-C3C5-4809-A465-DDC26B6021C5Q34061067-0A089DF9-4121-4B53-9608-4D802AAA1D1FQ34625779-984EB4CE-A9E4-43F6-B008-99768B0F80B8Q34939624-9153E20D-520B-4461-86F0-97E3CE13B69FQ35684498-E49CEB70-EC59-4158-AAB2-D93B631B7B20Q36225640-A2EA2D9E-E9C7-4FC7-B3E4-2416665A76BAQ36745642-D6D27587-97D5-46D7-9B54-0C91BE430590Q38202835-42CB939A-6A39-401D-8A01-A96EC56970CCQ38266283-BDF7430C-BEB3-4DC8-B9F8-1CFD386D7463Q43075742-2555BABF-DF20-4160-80BD-23E22CF50A93Q44345635-9540354F-DED2-4B49-B202-92BD6310ABA8Q51741932-D15491D1-3BF9-4BCD-B8E7-E6D5DBDD785CQ52316849-AC97FFCB-BF9E-4B1C-93A0-2396C63C8555Q57133342-91E60416-78CD-4F1C-A6A0-D3F307CB6D67
P2860
Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@ast
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@en
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@nl
type
label
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@ast
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@en
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@nl
prefLabel
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@ast
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@en
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@nl
P2093
P2860
P356
P1476
Clinically employed opioid ana ...... r heteromers in Rhesus monkeys
@en
P2093
Ajay S Yekkirala
Kenner C Rice
Mary M Lunzer
Matthew L Banks
Philip S Portoghese
Stevens S Negus
P2860
P356
10.1021/CN300049M
P407
P577
2012-09-19T00:00:00Z